(18.97.14.88)
[ij] [ij] [ij] 
Email id
 

Medicinal Plants - International Journal of Phytomedicines and Related Industries
Year : 2018, Volume : 10, Issue : 3
First page : ( 171) Last page : ( 175)
Print ISSN : 0975-4261. Online ISSN : 0975-6892.
Article DOI : 10.5958/0975-6892.2018.00028.X

Anti-Diabetic and Anti-Cancerous potential of citrus flavonoid naringin: A review

Sehrawat Nirmala1, Devi Sunita2, Devi Ashwanti1, Yadav Mukesh1,*

1Department of Biotechnology, Maharishi Markandeshwar (Deemed To Be University), Mullana-133207, Ambala, Haryana

2Government Ayurvedic Dispensary, Khandewla, Gurugram-122504, Haryana, India

*Corresponding author e-mail: mukeshyadav7@gmail.com

Online published on 6 September, 2018.

Abstract

Flavonoids are naturally occurring phenolic compounds with a diverse range of bioactivities. Naringin “C27H32O14” is a flavonoid compound present in citrus fruits. It contributes a characteristic bitter flavor to citrus fruit juice. Naringin and its aglycone naringenin exhibit various pharmacological actions. Investigations on naringin also revealed that its supplementation is beneficial for the treatment of obesity, diabetes and hypertension. Effect of naringin on cancer, diabetes, osteogenesis, osteoporosis, bone regeneration, cardioprotective, renoprotective, hepatoprotective and other systems has been reported. Diabetes and cancer are common diseases with great impact on health worldwide. Effect of naringin on diabetes and cancer has also been investigated. Present review focuses on anti-diabetic and anti-cancerous effect of naringin and its potential to be used as phytomedicine for possible cure of these diseases.

Top

Keywords

Flavonoid, naringin, citrus fruit, diabetes, cancer.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
885,647,184 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.